(2.5mg) Letrozole ''"""

Letrozole (2.5mg)
LETROZONE is a medication that is primarily used to treat breast cancer in postmenopausal women. LETROZONE belongs to a class of drugs known as aromatase inhibitors. Aromatase is an enzyme that plays a key role in the production of estrogen, a hormone that can promote the growth of certain types of breast cancer cells. By inhibiting aromatase, LETROZONE reduces the production of estrogen in the body, which can help slow down or stop the growth of estrogen-dependent breast tumors.
LETROZONE is commonly prescribed as an adjuvant (post-surgery) treatment for early-stage breast cancer in postmenopausal women. LETROZONE may also be used for advanced-stage breast cancer cases.
LETROZONE is particularly effective in treating hormone receptor-positive breast cancer, where the cancer cells have receptors for estrogen or progesterone. These receptors make the cancer cells more responsive to hormones like estrogen.
Steris Healthcare Pvt. Ltd. is a Leading Pharmaceutical Company in India. Established in the year of May 2018. We have 750+ Products & 16+ Super Specialty Segments. Every week we have a new product in our portfolio. In Last 4 years we are dealing in Chronic Therapy and in 4 years we grow by 200% Annually, because we deal in high quality medicine. Steris medicine manufactures at WHO-GMP Approved Plants & We have Legal manufacturing contracts with all leading manufacturers of India. Today we have 1000+ Business Franchise Partners in PAN India. Steris's medicine supply in India's Top or Reputed Hospitals, Pharmacy, Government use or Railway use. Grow with a similar pace with the STERIS. Be first to launch like us.
For further information please contact:
contact@sterispharma.com
order now:
https://www.sterisonline.com/product/letrozone-2-5-133664